Butensky & Cohen Financial Security’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Butensky & Cohen Financial Security's BMY Position: Q3 2017 in Review
Butensky & Cohen Financial Security sold out of Bristol-Myers Squibb (BMY) in Q3 2017, closing a stake of 190 shares — an estimated $11K sold.
Butensky & Cohen Financial Security first reported a position in BMY in Q2 2015 and held it in 9 quarters. The position peaked at $16K in Q4 2015. 1,642 funds tracked by Wall St. Rank hold BMY as of Q3 2017.
- Butensky & Cohen Financial Security reported no remaining Bristol-Myers Squibb position as of Q3 2017 after selling out during the quarter.
- Butensky & Cohen Financial Security sold 190 Bristol-Myers Squibb shares in Q3 2017, an estimated $11K.
- Butensky & Cohen Financial Security first reported a position in Bristol-Myers Squibb in Q2 2015 and held it in 9 quarters.
- Butensky & Cohen Financial Security's Bristol-Myers Squibb position peaked at $16K in Q4 2015.
- 1,642 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2017.
Based on Butensky & Cohen Financial Security's 13F filing for Q3 2017, filed 20 Oct 2017.